Supplementary Files
Keywords
Common variable immunodeficiency
X-linked agammaglobulinemia
Chronic granulomatous disease
Intravenous immunoglobulin
How to Cite
Plaudit
Abstract
Background: Primary immunodeficiencies are diseases that are caused by one or more defects in the immune system.
Objective: The purpose of the article is to describe the characteristics of the immunodeficiencies that were diagnosed in a pediatric hospital, which forms a reference center in the West of Mexico.
Methods: A cross-sectional study of pediatric patients with primary immunodeficiency in a pediatric hospital in Guadalajara, Jalisco.
Results: 60 patients were registered, of which 21% were female, and 78% were male. Predominant immunodeficiencies of antibodies formed the largest group (46% of patients). X-linked agammaglobulinemia was the most frequent immunodeficiency (21%); other frequent diagnoses were common variable immunodeficiency, and IgG subclass deficiency. The average age of the patients that were diagnosed was of 6.3 years. The most common initial manifestations were infectious processes (46%), and pneumonia was the frequent diagnosis (30%). Autoimmune manifestations were observed in 13% of patients; 67% of the patients were found with immunoglobulin replacement therapy, with which a decrease in hospitalizations from 3.2 times to 0.13 times was observed. There were two deceased patients due to surgical complications of cardiac correction and intestinal reconnection.
Conclusion: Knowing the behavior of primary immune deficiencies in our environment allows the opening of areas of opportunity in order to improve the survival and quality of life of our patients.
References
Raje N, Dinakar C. Overview of immunodeficiency disorders. Immunol Allergy Clin North Am. 2015;35(4):599-623. DOI: 10.1016/j.iac.2015.07.001
Bousfiha A, Jeddane L, Picard C, Ailal F, Gaspar HB, Chatila T, et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2018; 38(1):129-143. DOI: 10.1007/s10875-017-0465-8
Shillitoe B, Bangs C, Guzman D, Gennery AR, Slatter M, Longhurst HJ, et al. The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017. Clin Exp Immunol. 2018;192(3):284-291. DOI: 10.1111/cei.13125
Routes J, Abinun M, Al-Herz W, Bustamante J, Condino-Neto A, Etzioni A, et al. ICON: the early diagnosis of congenital immunodeficiencies. J Clin Immunol. 2014;34(4):398-424. DOI: 10.1007/s10875-014-0003-x
Veramendi-Espinoza LE, Zafra-Tanaka JH, Pérez-Casquino GA, Córdova-Calderón WO. Diagnostic delay of primary immunodeficiencies at a tertiary care hospital in Peru- brief report. J Clin Immunol. 2017;37(4):383-387. DOI: 10.1007/s10875-017-0398
Ochs HD, Hagin D. Primary immunodeficiency disorders: general classification, new molecular insights, and practical approach to diagnosis and treatment. Ann Allergy Asthma Immunol. 2014;112(6):489-495. DOI: 10.1016/j.anai.2014.04.007
Kilic SS, Ozel M, Hafizoglu D, Karaca NE, Aksu G, Kutukculer N. The prevalences and patient characteristics of primary immunodeficiency diseases in Turkey--two centers study. J Clin Immunol. 2013;33(1):74-83. DOI: 10.1007/s10875-012-9763-3
Martín-Nalda A, Soler-Palacín P, Español-Borén T, Urgelles C, Díaz-de Heredia-Rubio C, Figueras-Nadal C. Espectro de las inmunodeficiencias primarias en un hospital de tercer nivel en un periodo de 10 años. An Pedatr. 2011;74(2)74-83. DOI: 10.1016/j.anpedi.2010.09.019
Pedraza A, Vargas-Rumilla MI, Ramírez-Roa JL. Registro de inmunodeficiencias primarias en niños en un hospital de cuarto nivel. Bogotá, 2010-2016. Rev Alerg Mex. 2018;65(4):341-348. DOI: 10.29262/ram.v65i4.338
Berger M, Geng B, Cameron DW, Murphy LM, Schulman ES. Primary immune deficiency diseases as unrecognized causes of chronic respiratory disease. Respir Med. 2017;132:181-188. DOI: 10.1016/j.rmed.2017
Ramirez-Vargas N, Arablin-Oropeza S, Mojica-Martínez D, Yamazaki-Nakashimada MA, Terán-Juárez LM, Torres-Lozano C, et al. Clinical and immunological features of common variable immunodeficiency in Mexican patients. Allergol Immunopathol (Madr). 2014;42:235-240. DOI: 10.1016/j.aller.2013.01.007
Puck JM. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia. Immunol Rev. 2019;287(1):241-252. DOI: 10.1111/imr.12729
Orange JS, Grossman WJ, Navickis RJ, Wilkes MM. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies. Clin Immunol. 2010;137(1):21-30. DOI: 10.1016/j.clim.2010.06.012
Odabasi-Seeborg F, Seay R, Boyle M, Scalchunes C, Orange JS. Perceived health in patients with primary immune deficiency. J Clin Immunol. 2015;35(7):638-650. DOI: 10.1007/s10875-015-0196-7
Vivas-Rosales I, Hernández-Ojeda M, O’Farril-Romanillos P, Herrera-Sánchez DA, Maciel-Fierro AE, Núñez-Enríquez JC. Severidad de bronquiectasias en pacientes adultos con inmunodeficiencia común variable. Rev Alerg Mex. 2018;65:242-249. DOI: 10.29262/ram.v65i3.399
Lugo-Reyes SO, Ramírez-Vázquez G, Cruz-Hernández A, Medina-Torres, Ramírez-López AB, España-Cabrera C, et al. Clinical features, non-infectious manifestations and survival analysis of 161 children with primary immunodeficiency in Mexico: a single center experience over two decades. J Clin Immunol. 2016;36(1):56-65. DOI: 10.1007/s10875-015-0226-5
Guaní-Guerra E, Jiménez-Romero AI, García-Ramírez UN, Velázquez-Ávalos JM, Martínez-Guzmán E, Sandoval-Ramírez E, et al. Disease burden for patients with primary immunodeficiency diseases identified at reference hospitals in Guanajuato, Mexico. PLoS One. 2017;12(4):e0175867. DOI: 10.1371/journal.pone.0175867.
Griffit LM, Cowan MJ, Notarangelo LD, Kohn DB, Puck JM, Pai SY, et al. Primary Immune Deficiency Treatment Consortium (PIDTC) report. J Allergy Clin Immunol. 2014;133(2):335-347. DOI: 10.1016/j.jaci.2013.07.052
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2020 Revista Alergia México